Tecnun School of Engineering, University of Navarra, San Sebastián, Spain.
Biomedical Engineering Center, University of Navarra, Pamplona, Spain.
Biotechnol Bioeng. 2022 Oct;119(10):2698-2714. doi: 10.1002/bit.28182. Epub 2022 Jul 25.
Glaucoma is the leading cause of irreversible blindness worldwide and is characterized by the progressive degeneration of the optic nerve. Intraocular pressure (IOP), which is considered to be the main risk factor for glaucoma development, builds up in response to the resistance (resistance to what?) provided by the trabecular meshwork (TM) to aqueous humor (AH) outflow. Although the TM and its relationship to AH outflow have remained at the forefront of scientific interest, researchers remain uncertain regarding which mechanisms drive the deterioration of the TM. Current tissue-engineering fabrication techniques have come up with promising approaches to successfully recreate the TM. Nonetheless, more accurate models are needed to understand the factors that make glaucoma arise. In this review, we provide a chronological evaluation of the technological milestones that have taken place in the field of glaucoma research, and we conduct a comprehensive comparison of available TM fabrication technologies. Additionally, we also discuss AH perfusion platforms, since they are essential for the validation of these scaffolds, as well as pressure-outflow relationship studies and the discovery of new IOP-reduction therapies.
青光眼是全球范围内导致不可逆性失明的主要原因,其特征是视神经的进行性退化。眼内压(IOP)被认为是青光眼发展的主要危险因素,它会对房水(AH)流出的阻力(抵抗什么的阻力?)做出反应。尽管小梁网(TM)及其与 AH 流出的关系一直是科学关注的焦点,但研究人员仍不确定哪些机制导致 TM 恶化。目前的组织工程制造技术已经提出了有希望的方法来成功地重建 TM。然而,需要更精确的模型来了解导致青光眼发生的因素。在这篇综述中,我们按照时间顺序评估了青光眼研究领域所取得的技术里程碑,并对现有的 TM 制造技术进行了全面比较。此外,我们还讨论了 AH 灌注平台,因为它们对于这些支架的验证、压力-流出关系研究以及新的眼压降低疗法的发现至关重要。